ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "pharmacotherapy"

  • Abstract Number: 1772 • 2019 ACR/ARP Annual Meeting

    Chronotherapy Using Baricitinib Attenuates Collagen-induced Arthritis in Mice

    Arisa Yaekura1, Kanta Morii 2, Yuto Oketani 3, Ikumi Okumura 2, Kenta Kaneshiro 4, Kohsuke Yoshida 2, Yoshiko Kawasaki 5, Nao Shibanuma 5, Yoshitada Sakai 6 and Akira Hashiramoto 2, 1Kobe University Graduate School of Health Sciences, Kawanishi, Hyogo, Japan, 2Kobe University Graduate School of Health Sciences, Kobe, Hyogo, Japan, 3Kobe University Graduate School of Health Sciences, Himeji, Hyogo, Japan, 4Kobe University Graduate School of Health Sciences, Osaka, Osaka, Japan, 5Kobe Kaisei Hospital, Kobe, Hyogo, Japan, 6Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan

    Background/Purpose: Diurnal variations are observed in symptoms of rheumatoid arthritis (RA). Among them, “morning stiffness of joints” is closely reflects the daily medical condition of…
  • Abstract Number: 2399 • 2019 ACR/ARP Annual Meeting

    Changes in the Initial Usage Pattern of Biologic Disease-modifying Antirheumatic Drugs in Rheumatic Diseases During the past Twelve Years: A Real-world Setting Analysis

    Carlos Sánchez-Piedra1, María Colazo 2, Rosa Roselló 3, Cristina Campos 4, P. Vela 5, Cristina Bohorquez 6, Carolina Pérez-García 7, Manuel Pombo-Suarez 8, Carlos Fernández-López 9, Dolores Ruiz-Montesinos 10, Fernando Alonso 11, Federico Diaz-Gonzalez 12 and Juan Jesús Gómez-Reino 13, 1Research Unit, Spanish Society of Rheumatology, Madrid, Spain, 2Hospital de Burgos, Burgos, 3Hospital San Jorge, Huesca, 4Hospital General de Valencia, Valencia, 5Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, Spain, 6Universitary Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology department, Alcala de Henares, Spain, 7Rheumatology, Hospital del Mar, Barcelona, Catalonia, Spain, 8Unit Research, Spanish Society of Rheumatology, Madrid, Spain, 9Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 10Hospital Virgen Macarena, Sevilla, 11Unidad Investigación SER, Madrid, Spain, 12Hospital de Canarias, Tenerife, 13Hospital de Santiago, Santiago de Compostela

    Background/Purpose: During the past 15 years, advancements in the understanding of the safety and effectiveness, as well as the expanding access and availability of biologic…
  • Abstract Number: 2580 • 2019 ACR/ARP Annual Meeting

    Pharmacotherapies Targeting Type 2 SLE Symptoms

    Raeann Whitney1, Amanda Eudy 1, Megan Clowse 1, Lisa Criscione-Schreiber 1, Jayanth Doss 1, David Pisetsky 2, Kai Sun 1, Rebecca Sadun 1 and Jennifer Rogers 1, 1Duke University, Durham, 2Duke University, Durham VAMC, Durham

    Background/Purpose: We propose categorizing lupus activity to better align with patient experience: Type 1 SLE activity includes classic symptoms such as arthritis and nephritis; Type…
  • Abstract Number: 1166 • 2017 ACR/ARHP Annual Meeting

    Systemic Degos Disease: Long Term Survival on Combined Therapy with Eculizumab and Treprostinil

    Lee S. Shapiro1,2, Jessica Farrell1,2,3, Roberta Lukasiewicz1,2, Peter A. Merkel4, Douglas Rosing5, Manfred Boehm6, Axia Toledo-Garcia1, Maria Karas7, Maria DeSancho8, Harry McCoy9, Michael Marmulstein10 and Scott Beegle11, 1The Center for Rheumatology, Albany, NY, 2Steffens Scleroderma Center, Albany, NY, 3Pharmacy Practice, Albany College of Pharmacy & Health Sciences, Albany, NY, 4Division of Rheumatology, University of Pennsylvania, Philadelphia, MN, 5Cardiovascular Pulmonary Branch, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, 6Center for Molecular Medicine, NHLBI/ NIH, Bethesda, MD, 7Division of Cardiology/Department of Medicine,, Weill Cornell Medical College, New York, NY, 8Weill Cornell Medical Center, New York, NY, 9Blue Ridge Cancer Care, Blacksburg, VA, 10Albany Associates in Cardiology, Albany, NY, 11Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY

    Background/Purpose: Degos disease (Malignant Atrophic Papulosis) is a thrombotic microvasculopathy of complement activation, endothelial cell injury and progressive microvascular obliteration.  Lesions are marked by vascular…
  • Abstract Number: 2206 • 2016 ACR/ARHP Annual Meeting

    Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)

    José E. Martinez1,2, Marcelo C. Rezende1,3, Eduardo Paiva1,4, Daniel Pollak1,5, Milton Helfenstein Jr1,6, Jose Roberto Provenza1,7, Aline Ranzolin1,8, Luiz Severiano Ribeiro1,9, Eduardo J. R. Souza1,10, Roberto E Heymann1,11 and Marcos Renato Assis1,12, 1Brazilian Society of Rheumatology, São Paulo, Brazil, 2Rheumatology, Pontificia Universidade Católica de São Paulo, Sorocaba, Brazil, 3Santa Casa de Campo Grande, Campo Grande, Brazil, 4Rheumatology, Universidade Federal do Parana, Curitiba Parana, Brazil, 5Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 6RUA JOAO DE LACERDA SOARES, 90, Universidade Federal de São Paulo, Sao Paulo, Brazil, 7Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, 8Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, 9Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, 10Santa Casa de Belo Horizonte, Belo Horizonte, Brazil, 11Universidade Federal de São Paulo, São Paulo, Brazil, 12Rheumatology, Faculdade de Medicina de Marilia, Marilia, Brazil

    Background/Purpose: The Brazilian registry on fibromyalgia syndrome (EpiFibro) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
  • Abstract Number: 3152 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis (RA): Premature Use of Biologics Accelerating in United States (US)

    James R. O'Dell1, Stanley B. Cohen2, J Carter Thorne3 and Ted R Mikuls4, 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 2Metroplex Clinical Research Center, Dallas, TX, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The treatment of RA has changed dramatically in the past several decades with the advent of a large number of new biologic agents as…
  • Abstract Number: 1492 • 2015 ACR/ARHP Annual Meeting

    Implementation in Clinical Practice of a Medication Assessment Tool Specific for Rheumatoid Arthritis, Rhmat

    Louise Grech1,2, Anthony Serracino Inglott1, Victor Ferrito1 and Lilian M. Azzopardi1, 1Department of Pharmacy, University of Malta, Msida, Malta, 2Clinical Pharmacy Practice Unit, Department of Pharmacy, Mater Dei Hospital, Msida, Malta

    Background/Purpose: The RhMAT is a medication assessment tool developed to specifically analyse pharmacotherapy adherence to evidence based medicine and guidelines on the management of rheumatoid…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.